Access Keys:
Skip to content (Access Key - 0)

Center For Cancer Research DCEG National Cancer Institute

NCI Center of Excellence in Integrative Cancer Biology and Genomics

The Center of Excellence in Integrative Cancer Biology and Genomics (CEICBG) is one of four Centers of Excellence established within the NCI Intramural Research Program (IRP). The Centers of Excellence build upon existing structures and areas of expertise. They lead new initiatives, projects, and collaborations, and position the IRP to play a significant role in interdisciplinary and multidisciplinary translational research. The CEICBG is a steward of resources and infrastructure, promotes interactions among NCI principal investigators and with other Institutes, extramural investigators, and the private sector, and provides leadership in facilitating new initiatives in cancer biology and genomics.

The CEICBG will promote the innovative use of genetic and genomic approaches and technologies for basic science discoveries and clinical research applications for the prevention, diagnosis, and treatment of cancer.

Objectives

  • Strengthen interactions across the IRP by providing a unique research environment and a capacity to take on "big" high risk projects
  • Enhance collaborative network among principal investigators and interactions with other NCI centers and programs
  • Consolidate existing cancer databases
  • Maximize utilization and accessibility of animal models
  • Expand core facilities
  • Provide a venue for annual meetings with participation from extramural scientists

To learn about recent advances by Center researchers, click on the images above.

Special Notices/Announcements

 

CEICBG Symposium

November 10, 2016
1:00pm- 4:00pm

Building 35, Room 620/630, NIH Bethesda campus

Program

Keynote speaker- Nir Hacohen
Massachusetts General Hospital
" A Genomic View of Cancer Immunology and Immunotherapy"

Amiran Dzutsev
Cancer and Inflammation Program, CCR, NCI
" Human Th22 and Th17 Cell Differentiation through the Lens of Single Cell Sequencing"

Christopher Chien
Pediatric Oncology Branch, CCR, NCI
" Defining TSLPR as a Functionally Relevant Target for CAR T Cell Therapy"

Olusegun Onabajo
Laboratory of Translational Genomics, DCEG, NCI
" The Good and the Bad of Type III Interferons in Cancer: From Genetic Association to Functional and Clinical Studies"

Anna Coghill
Infections and Immunoepidemiology Branch, DCEG, NCI
" Utilizing Markers of the Immune Response to Epstein-Barr Virus to Inform Cancer Prevention"

For the flyer  click here

Current jobs in the CCR

Added by Shilling, Jeffrey (NIH/NCI) [E] , last edited by Hooper, Laura (NIH/NCI) [E] on Oct 31, 2016 11:44 AM